Agilex Biolabs Taps Biopharma Leader Dr Caroline Popper for Board Chair as part of...

Adelaide, AUS - (ACN Newswire) - Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as...

Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial

        Hua Medicine (the "Company", Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today...

AIM ImmunoTech提供2020年第二季度業務更新並報告COVID-19和癌症試驗進展

免疫藥物公司AIM ImmunoTech(NYSE- American 交易代碼: AIM) 是一家致力於研究治療免疫疾病,病毒性疾病和多種類型癌症的療法的免疫藥物公司,今天提供了截至2020年6月30日的第二季度業務和臨床前/臨床更新。 2020年第二季度財務摘要: - 截至2020年6月30日,AIM的現金,現金等價物和有價證券為4030萬美元,而截至2019年12月31日為880萬美元。 - 截至2020年6月30日的第二季度的研發費用為146萬美元,而截至2019年6月30日的第二季度的研發費用為110萬美元。 - 截至2020年6月30日的第二季度的一般和行政支出為172萬美元,而截至2019年6月30日的第二季度的194萬美元。 公司的2020年6月30日完整財務業績包含在於2020年8月14日提交給美國證券交易委員會的10-Q表內,該表格可從www.sec.gov和公司網站上獲得。 “ AIM致力於滿足COVID-19和癌症等關鍵未滿足的醫療需求的極其重要且具有開創性的臨床前和臨床研究,這為我們在廣闊的潛在市場中提供了“多重目標”。根據這些多種表現,AIM支持這些試驗的策略是最大限度地增加直接授予臨床站點的第三方,非稀釋性資金,是我們在許多試驗中均已完成的。此外,截至2020年6月30日,我們的資產負債表上有超過4,000萬美元的現金,現金等價物和有價證券。因此,我們相信,我們非常有能力執行未來的戰略,反過來,我們預計將為股東帶來可觀的價值。” AIM首席執行官Thomas K. Equels說。 COVID-19常規更新: - 在FDA於2020年5月11日批准IND後,AIM於2020年7月6日與Roswell Park 綜合癌症中心簽署了一項臨床試驗協議,以支持Roswell Park Ampligen與乾擾素alfa-2b聯合治療的1 / 2a期臨床試驗在患有COVID-19的癌症患者中,該疾病由SARS-CoV-2引起。該試驗有望很快開始患者入組。 - AIM與日本國立傳染病研究所和 Shionogi 公司簽署了三邊材料轉移和研究協議, Shionogi...

BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity

BioVaxys Technology Corp. (CSE: BIOV) ("BioVaxys" or "the Company"), a world leader in haptenized protein vaccine research and development, announced today that it has...

Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation...

Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale...

Steady Development in Kingworld 25th Anniversary and Deepening Management New Journey in Pursuit of...

Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading global well-known omni-channel enterprise offering a complete supply chain spanning...

Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau

Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of...

Agilex Biolabs宣布将实验室扩充30%,并在COVID-19疫情爆发期间提供虚拟实验室参观服务

屡获殊荣的澳大利亚生物分析实验室Agilex Biolabs今天宣布,其实验室设施已扩充了30%以上,以满足主要来自美国和亚太地区生物技术公司的需求。 Agilex Biolabs是该地区唯一经过美国食品和药物管理局(FDA)认证的该类实验室,它位于南澳大利亚州阿德莱德市的一个科学和生物技术专家中心。 该公司利用液相色谱串联质谱(LC-MS/MS)和Immunoassay(免疫分析) (MesoScale,Gyrolab)两个平台,专门进行小分子生物分析和PK生物制剂、免疫原性和生物指标的研究。 Agilex还提供药效学服务,包括使用最先进的技术支持免疫学、细胞生物学和作用方式分析的免疫生物学服务,包括: - 免疫表型 - 受体占用 - 细胞因子释放试验(全血或外周单个核细胞(PBMC)刺激试验)和细胞因子/生物标志物分析 - PBMC测定和细胞作用机制分析(例如:抗体依赖的细胞介导的细胞毒性作用(ADCC)) Agilex Biolabs的首席执行官Jason Valentine说,公司现在准备提供虚拟实验室参观服务,以满足当前由于Covid-19疫情爆发而不便出行的客户需求。 首席执行官Jason Valentine说: “我们经过FDA认证的设备拥有超过65名专门的实验室工作人员,并且每年为80多项临床试验提供支持。 今年,我们将分析来自美国、欧洲和亚太地区的6万多个制药/生物技术样本。” “专业的知识、技术创新再加上20年的从业记录,迄今为止我们已经为全球数百项临床前和临床试验提供了支持。” “我们世界级的生物分析设备获得了NATA(澳大利亚政府良好实验室规范合规监测机构)良好实验室规范(OECD GLP)认证和ISO 17025全球认证。” 点击此处了解更多关于Agilex Biolabs的信息(视频) https://youtu.be/3lyodiqqM_k 通讯方式 澳大利亚: +61 8 83028777 美国:+1 800 247 1909 https://www.agilexbiolabs.com/contact-us/ 关于Agilex Biolabshttps://www.agilexbiolabs.com/ Agilex Biolabs成立于20世纪80年代,最初是由一群为澳大利亚本地制药行业提供临床试验和生物分析服务的学术科学家发起的,现在已经发展成为一家从事早期临床试验的全球性企业。在我们进行小分子和大分子的受控生物分析的20年间,我们已经在全球各地推动进行了数百项临床前和临床试验。如今,我们的客户包括许多来自亚洲、欧洲和美国的一流制药和生物技术公司。 Agilex Biolabs有四个推动业绩的核心价值: -...

Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes

SYDNEY - Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review...

Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can...

The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on...

Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of...

Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; Hong Kong stock code: 00575), a specialist healthcare,...

Olympus Grows Respiratory Portfolio with Acquisition of Veran Medical Technologies

Strategic acquisition drives Olympus expansion of its Respiratory Solutions Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran...

Captiva Verde Enters into Negotiations to Acquire Licensed Applicant of Outdoor High Potency Organic...

Coquitlam, British Columbia - (ACN Newswire) - Captiva Verde Land Corp. (the "Company") (CSE: PWR), is pleased to announce that negotiations have commenced to acquire Solargram Farms...

TransCanna Announces Closing of CDN$10 Million Brokered Private Placement of Units

TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (OTC PINK: TCNAF) ("TransCanna" or the "Company") is pleased to announce that it has closed its previously...

TransCanna Hits Initial Revenue Target

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that the company has reached its initial revenue target...

Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology...

Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, is pleased to announce that Dr. Fuxing Tang has joined Hua Medicine as...

InnoCare, a Star Biomedical Company with Edge in New Drugs, Is Listed Today

InnoCare Pharma Limited ("InnoCare" or the "Company") (09969.HK), as the first listed biotech company in 2020, is listed on the Main Board of the...

Sino Biopharmaceutical Announces 2020 First Quarterly Results

Revenue was approximately RMB6.22 Billion; Profit Attributable to Owners of the Parent was approximately RMB862 Million Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with...

Epazz DeskFlex Desk and Room Scheduling System Automates Desk Sanitation as Preventive Measures to...

Desk Scheduling System Helps Prevent the Onset of COVID-19 Infection in the Workplace with its Automatic Scheduling of Cleaning NEWMEDIAWIRE - Epazz, Inc. DeskFlex (OTC: EPAZ),...

Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

  Olympus Corporation today announced the launch of ENDO-AID(1), a cutting-edge platform powered by artificial intelligence (AI) that includes the endoscopy application ENDO-AID CADe (computer-aided...

Lotto Results

Ultra Lotto 6/58 result

6/58 Ultra Lotto Result Today and Winning Number History from PCSO

Ultra Lotto 6/58 has the biggest initial jackpot in all of the games of Philippine Charity Sweepstakes Office (PCSO) at P133 million (net of...
Ultra Lotto 6/58 result

PCSO 6/58 Ultra Lotto Result Today January 26, 2021 Tuesday

Looking for the winning combination for 6/58 Ultra Lotto Result today? Here is the official result for Tuesday, January 26, 2021 based on the...
6/49 Super Lotto Result Today

6/49 Super Lotto Result Today and Winning Numbers History from PCSO

Check your tickets here! Know the latest 6/49 Super Lotto Result Today based on the official draw of the Philippine Charity Sweepstakes Office (PCSO). PCSO...
6/49 Super Lotto Result Today

6/49 Super Lotto Result Today for January 26, 2021 Tuesday from PCSO

MANILA, Philippines - The Philippine Charity Sweepstakes Office (PCSO) will release the 6/49 Super Lotto Result today, January 26, 2021, Tuesday, with an estimated...
6/42 Lotto Result Today

6/42 LOTTO RESULT TODAY – 6/42 PCSO Lotto Result

METRO MANILA - Looking for the latest 6/42 lotto result today? Here is the latest result from the Philippine Charity Sweepstakes Office (PCSO) for...